1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow odronextamab: new trials by email Literature Review of odronextamab trials Research Report on odronextamab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies cemiplimab, odronextamab - Relapsed/Refractory Aggressive B-Cell Lymphoma | Phase 1 | Completed | Regeneron Pharmaceuticals | 105 | 2016-01-11 | 2026-06-02 |
Lymphoma, B-Cell (1) · Recurrence (1)
Austria (1) · Germany (1) · Israel (1) · Poland (1) · Spain (1) · United States (1)
2015 (1), 2023 (1)